SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ConforMIS, Inc. â€“ CFMS
NEW YORK, NY / CRWEPRESSRELEASE / August 31, 2015 /Pomerantz LLP is investigating claims on behalf of investors of ConforMIS, Inc. (“ConforMIS” or the “Company”) (NASDAQ: CFMS). Such investors are advised to contact Robert S. Willoughby at email@example.com or 888-476-6529, ext. 9980.
The investigation concerns whether ConforMIS and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On August 31, 2015, pre-market, ConforMIS announced that it has initiated a voluntary recall of specific serial numbers of patient-specific instrumentation for certain of its knee replacement product systems, in response to recent complaints of moisture on the instrumentation. A total of approximately 950 patient-specific instrumentation sets are affected by this recall.
On this news, the company’s stock fell as much as 4.23, or 21.4%, on intraday trading on August 31, 2015.
The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Florida, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlawfirm.com.